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Abstract
Estrogen receptor-a (ER) transcription function is regulated in a ligand-dependent (e.g., estradiol, E2) or ligand-independent
(e.g., growth factors) manner. Our laboratory seeks to understand these two modes of action. Using a cell line that contains
a visible prolactin enhancer/promoter array (PRL-HeLa) regulated by ER, we analyzed ER response to E2 and EGF by
quantifying image-based results. Data show differential recruitment of GFP-ER to the array, with the AF1 domain playing a
vital role in EGF-mediated responsiveness. Temporal analyses of large-scale chromatin dynamics, and accumulation of array-
localized reporter mRNA over 24 hours showed that the EGF response consists of a single pulse of reporter mRNA
accumulation concomitant with transient increase in array decondensation. Estradiol induced a novel cyclical pattern of
mRNA accumulation with a sustained increase in array decondensation. Collectively, our work shows that there is a stimuli-
specific pattern of large-scale chromatin modification and transcript levels by ER.
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Introduction
The estrogen receptor-a (ER) integrates signals from different
stimuli in its role as a transcription regulator. The transcriptional
activity of ER is regulated directly through binding of estrogenic or
anti-estrogenic molecules [1]. Indirectly it is regulated by growth
factor signaling pathways [2,3]. Although there is overlap with
direct activation, growth factors activate kinase cascades resulting
in phosphorylation and activation of the ER, which is distinguish-
able from ligand activation [4]. Indeed, cross talk between the
regulatory pathways indicates that direct and indirect regulation of
ER are not mutually exclusive [4–6]. Epidermal growth factor
(EGF) and its receptor, EGFR, initiate an important signaling
cascade leading to an activated ER [7]. It has been hypothesized
that the combined over-stimulation of ER and the EGF receptor
(EGFR) may provide a strong stimulus for breast tumor growth
and may contribute to the resistance of tumor cells to antagonist
therapy. The molecular mechanism of this activation remains
poorly understood and is an area of continued study [8–10].
EGF signaling is initiated by binding and activation of the
EGFR at the plasma membrane [11]. Tyrosine autophosphoryla-
tion by EGFR initiates multiple kinase cascades, targets of which
include the ER. EGF induces ER-dependent stimulation of
estrogen responsive element (ERE) reporter expression [12]. In
this model, the extracellular EGF signal is transduced to genes
regulated by the ER, the physiological relevance of which is
underlined by estrogen-like effects of EGF on the mouse uterus do
not occur in ER-deficient transgenic mice [13].
ERK1 and ERK2, kinases belonging to the MAPK pathway,
have been shown to phosphorylate the ER at serine 118 in the
activation function-1 (AF-1) domain of ER [3,14]. This post-
translational modification has a strong impact on ER-mediated
transcriptional activation induced by both direct (estradiol) and
indirect signaling [15,16]. Interestingly, ER phosphorylation at
serine 118 is also a marker of an activated ER signaling pathway in
breast cancer, and provides a precise biomarker of responsiveness
to endocrine therapy [17,18]. Therefore, elucidation of the
mechanism of EGF-dependant activation of ER could be
important in the development of new therapeutic targets for
overcoming the resistance of breast tumor cells to hormone-
therapy.
We have developed a model system, PRL-HeLa, for the single-
cell study of multiple mechanistic aspects of ER regulation of
transcription [19]. This cell line contains a multi-copy integrated
prolactin (PRL) enhancer/promoter reporter construct, which is
responsive to E2. When ER is expressed as a GFP-fusion protein
(GFP-ER), the integration site can be easily visualized allowing
spatial and temporal analyses of promoter/enhancer targeting by
ER, large-scale chromatin modification and accumulation of
reporter mRNA. In our initial studies, we used PRL-HeLa to
examine ligand-dependent ER regulation [19]. Treatment of these
cells with E2 induces an ER-dependent large-scale chromatin
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mRNA accumulation. Conversely, treatment with the anti-
estrogen 4-hydroxy-tamoxifen (4HT) induces large-scale chroma-
tin condensation, abrogates coactivator recruitment, concomitant
with a marked repression of reporter gene transcription. PRL-
HeLa can be used to simultaneously examine several mechanistic
aspects of ER transcription regulation at early (minutes) or late
(hours) stages.
ER is an important regulator of pituitary function, and the
expression of the prolactin gene is also responsive to other factors,
including EGF [20]. Accordingly, we sought to compare indirect
(E2)- and indirect (EGF)-responsive regulation of ER-mediated
transcription using our PRL-HeLa model system. Using quanti-
tative automated imaging [21], our studies reveal differential
recruitment of GFP-ER to the PRL array, sustained, maximum
chromatin decondensation over 24 hours in E2 treated cells,
accompanied by cyclic levels of reporter mRNA accumulation at
the PRL-array. In contrast, EGF treatment induces a single pulse
of ER-dependent chromatin decondensation and mRNA accu-
mulation. These studies indicate a previously unknown difference
between ligand-dependent and -independent control of chromatin
decondensation by ER, coincident with different transcriptional
responses.
Results
EGF-dependent ER promoter targeting
PRL-HeLa cells transiently transfected with a GFP-ER
expression vector were maintained for 48 hours in a hormone-
free medium, and were then treated with 10 nM E2, 100 ng/ml
EGF or 10 nM 4HT. PRL-arrays were visualized as bright foci of
nuclear fluorescence in GFP-ER-expressing cells (Figure 1A,
arrows), These foci co-localize with the integrated PRL reporter
chromatin by DNA and RNA fluorescence in situ hybridization
(FISH) [19]. Transient transfection results in a range of protein
expression [19,21], and analyses of individual cells require careful
selection based upon fluorescence (GFP-ER) level [21]. To avoid
overexpression issues, array responses were assayed in cells
expressing GFP-ER at levels of ,1.5 fold compared to
endogenous ER in MCF-7 cells [19]. Relative to vehicle control,
both E2 and 4HT treatments result in an increase in the
percentage of cells with visible PRL arrays in GFP-ER expressing
cells (60% versus 100% and 100%, respectively, Figure 1B). EGF
treatment (indirect activation) resulted in 78% of GFP-expressing
cells demonstrating visible arrays, which is statistically greater than
vehicle control, but lower in percentage than E2-treated (direct
activation).
To determine the functional domains of ER required for EGF-
mediated array responses, we expressed previously described
deletion mutants (Figure 2 and [19]). Consistent with previous
observations [19], expression of mutated ER in which the AF1 and
DNA binding domain (GFP-ER251–595), or the ligand-binding
domain (GFP-ER1–282) are deleted resulted in diffuse nuclear
fluorescence (no visible foci) regardless of treatment (Figure 2 and
Table 1). Expression of receptor in which the AF-1 domain (GFP-
ER179–595) is removed demonstrated PRL-array targeting in the
presence of E2, but not EGF (Figure 2). Therefore, the activity of
the AF1 transactivation domain in the ER is necessary, but not
sufficient, for optimal EGF-induced association with the PRL-
array.
Expression of GFP-ER1–534 (deleted for the F-domain and helix
12 of the E domain) resulted in PRL-array targeting with E2
treatment, but not EGF (Figure 2 and Table 1). Consistent with
previous observations [19], the PRL-array remained condensed in
cells treated with E2 (Figure 2), confirming that helix 12 is
necessary for E2- induced large-scale chromatin decondensation.
EGF treatment of cells expressing GFP-ER1–554 (deleted for the F-
domain) resulted in array targeting, which was indistinguishable
from wild type ER (data not shown). These data exclude the
involvement of the F domain in the observed differential
recruitment to the PRL-array. To summarize these mapping
experiments, both the AF1 and AF2 domains (helix 12) appear
necessary for ER interactions with the PRL array.
Based on these differential responses, we next assayed
coregulator recruitment in each setting. E2 and EGF each
induced recruitment of p160 coregulators SRC-1/SRC-3, the
chromatin remodeling protein BRG1, and both CDK7 and
cyclin D1 (each involved in transcriptional elongation) to the
PRL-array in cells expressing wild type GFP-ER (Figure S1).
Confirming the specificity of the immunostaining reagents, cells
Figure 1. Estrogen receptor promoter binding in PRL-HeLa cells. GFP-ER was transiently expressed in PRL-HeLa cells and then treated with
ethanolic vehicle, 17-b estradiol, EGF or 4-hydroxytamoxifen for 2 hours prior to fixation. Each ligand concentration was 10 nM except for EGF, which
was 100 ng/ml. A. Representative images of PRL-HeLa cells treated with EGF. Arrowheads point to visible arrays in two cells. One of the cells has two
fluorescent foci/arrays, while the other has one larger focus. B The percentage of each cell population that has visible accumulation at the array in
response to each treatment has been calculated and graphed (n.200). Bars indicate Standard Deviations from 3 different experiments. Student t-test
was performed for each bar compared to vehicle treatment. *p,0.05.
doi:10.1371/journal.pone.0002286.g001
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able association of these co-regulators. Based on our set of
immunological reagents, these data indicate that EGF signaling
through ER recruits a similar set of coregulators at the PRL
array.
Temporal Large-Scale Chromatin Modification
To further explore E2 and EGF stimulation of ER, we
performed time-course treatments (0–24 hours) and cytomorpho-
metric analysis of large-scale chromatin modification by high-
throughput microscopy (HTM). This new quantitative imaging
Figure 2. Role of AF-1 and AF-2 ER domains in promoter binding. Representative images of PRL-HeLa cells transiently expressing the
indicated deletion mutants and treated with either ethanolic vehicle, E2 or EGF for 2 hours (see Table 1). The inset images are representative of
fluorescence images observed in a minority of cells. The size bar is in microns. All images were captured so as to optimize the intensity of the GFP-ER.
doi:10.1371/journal.pone.0002286.g002
Table 1. Promoter targeting and chromatin status in PRL-HeLa for ER deletion mutants.
wt 251–595 1–282 179–595 1–534
vehicle 60% (62.8) decondensed 0% 0% 22.5% (63.5)* decondensed 0%
E2 100% decondensed 0% 0% 89.5% (60.7)*,{ decondensed 100% condensed
EGF 78% (64) decondensed 0% 0% 19% (62.8)* decondensed 3% (60.01) condensed
*p,0.03 versus respective wt.
{p,0.03 versus wt-EGF.
doi:10.1371/journal.pone.0002286.t001
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those cells expressing a physiological level of GFP-ER (See
Materials and Methods).
In concert with previous live cell results [19], E2 treatment is
associated with a rapid decondensation of the PRL-array that
reaches its maximum expansion in ,15 minutes and, as shown in
(Figure 3A), plateaus for at least 24 hours. In contrast, treatment
of GFP-ER expressing cells with EGF resulted in a transient
decondensation of the array, with full recondensation in about
2 hours (Figure 3A). A more detailed analysis of the early time
period during expansion and contraction of the array is shown in
Figure 3B. Note that EGF induced large-scale chromatin
modification was slower than E2; ,30 minutes for peak expansion
with EGF compared to ,15 minutes for E2. This EGF result is
illustrated by time-lapse imaging of live cells shown in Figure 3C.
We next determined if these stimuli-induced changes in large-
scale chromatin persist upon removal of E2 or EGF. Results
showed that the area of the PRL-array gradually decreased, and
reached basal (no treatment) condensation by approximately
2 hours after removal of E2 (Figure S2). Upon removal of EGF,
the array experiences a steeper rate of condensation compared to
E2 (Figure S2). Note that both E2 and EGF failed to change the
size of the array in non-transfected cells, in which the array was
immunolabeled with antibodies specific for RNA polymerase II or
dimethlylated histone H3 (K4) (data not shown).
ER-mediated transcriptional activity at the single cell
level
To examine the relationship between array size and transcrip-
tional responses to EGF, E2 or 4HT, we next used RNA FISH to
measure dsRED2skl mRNA accumulation at the array
(Figure 4A). Restorative deconvolved image stacks from GFP-
ER and hybridization signals (array-associated transcripts) were
collected and quantified as a measure of co-localizing reporter
mRNA. First we examined the entire range of the expression
within the transiently transfected cell population to determine if
there was a cell-to-cell correlation between GFP-ER expression
levels and the quantified FISH signal. In the PRL-HeLa cells that
were non-transfected (fluorescence mean intensity was ,,500,
Figure 4B, yellow circles), there was a low level of FISH signal
detectable at the array (Figure 4A, inset value). Cell gating
based upon ER expression level indicated a suppression of
reporter transcript accumulation in cells overexpressing the
receptor (GFP-ER mean intensity in the nucleus ,.8000,
Figure 4B, blue circles; intensity value .1.5fold compared to
MCF-7 cells). In the remaining cells with low levels of GFP-ER
(,400062000, Figure 4B, red circles), FISH signals were not
linearly dependent on fluorescence (receptor) levels, suggesting
possible involvement of both expression level and an asynchronous
cell population [22]. These observations led us to analyze cells
with low levels of fluorescence (mean intensity,,6000) in the
following experiments.
In the E2 and EGF-treated cells, the mRNA transcripts at the
PRL-array dramatically increased in comparison with both of the
non-transfected cells and the vehicle treated cells (Figure 4A see
the corresponding inset values). Treatment with 4HT repressed
the accumulation of reporter transcripts at the PRL-array (see the
arrows in the GFP-ER panel and the corresponding RNA FISH
panel, Figure 4A) to levels below that of non-transfected cells or
vehicle controls. In all cases, the transcriptional activity at the
PRL-array correlated with the detection (or absence for 4HT-
treated cells) of endogenous RNA polymerase II, which co-
localized with the array (Figure S3).
We then ask: do the timing differences in the PRL-array
condensation/decondensation upon E2 or EGF treatment (See
Figure 3A) correlate with changes in transcript accumulation at
the array and, more precisely, is peak chromatin decondensation
at the PRL-array co-incident with maximum co-localizing
transcripts? To address this question, we performed quantitative
RNA FISH at regular time intervals (0–24 hours) after treatment
of PRL-HeLa cells expressing GFP-ER with E2 or EGF. Results
showed that EGF treatment leads to a strong, single pulse of
transcript accumulation at the array ((2.8 fold of vehicle)
Figure 4C), consistent with its ability to induce an increase in
the area of the PRL-array (Figure 3A), both of which
demonstrate similar temporal dynamics. Maximal FISH signal
peaked at 30 minutes of treatment, declined sharply (approxi-
mately 40%) at one hour post treatment, and from there they
gradually returned to basal (vehicle levels) by 4 hours (p.0.05,
Figure 4C). By measuring the decay rate (l) of the graph from an
exponential curve fit, we observed that the change in array size
was slower when compared with the reduction of transcriptional
activity (l=0.026/h and l=0.063/h respectively).
In E2-treated PRL-HeLa cells expressing GFP-ER, a temporal
analysis of RNA FISH showed a dramatically different pattern of
reporter mRNA accumulation at the array (Figure 4C). While
the PRL-array remained maximally decondensed (Figure 3A),
the levels of reporter gene mRNA showed cyclical fluctuations
over a 24-hour period (Figure 4C). Similar to the EGF treatment,
FISH signals at the PRL-array peaked at 30 minutes post E2
treatment reaching 3.5 fold over basal levels, which is significantly
higher (p=0.03) than that induced by EGF (2.8 fold). From this
point on in the 24-hour treatment period, the E2 transcription
response at the PRL array was very different. The decline in FISH
signal showed a slower rate of decrease compared to EGF reaching
basal levels in ,2–3 hours. At arrays that are fully decondensed
(Figure 3A), E2 treatment induced a second peak of mRNA
accumulation around 4 hours post-treatment (2.5 fold higher than
non-treated control cells). By 2–3 hours after this point, transcript
levels again decreased to vehicle-treated values. Interestingly,
24 hours after beginning E2 treatment, mRNA levels at the array
again increased to a level ,50% higher than control cells.
Antagonist treatment (4HT) rapidly (within 15 minutes) repressed
transcriptional activity, with no fluctuations (Figure 4C) con-
comitant with tight array condensation [19]. Collectively, these
results identify an agonist-ligand-specific wave-pattern of mRNA
accumulation at the PRL array by sustained E2 treatment versus a
single pulse pattern of mRNA accumulation during EGF
activation.
Cell Signaling and ER-mediated transcription
To further test EGF-dependent pathways in ER-mediated
activation of the PRL array, we used an inhibitor of EGFR
autophosphorylation (Tyrphostin AG537) in our assays
(Figure 5A–C) described above. Among all cells expressing
GFP-ER, EGF plus AG 537 treatments resulted in a 66%
reduction (relative to EGF alone control) in array targeting
(Figure 5A). Furthermore, array size and mRNA accumulation
among the few (20%), positive cells) was similar to the control
vehicle-treated cells (Figure 5B and C), indicating that both
large-scale chromatin decondensation and reporter gene induction
by ER were inhibited. As expected, the inhibitor had no effect on
the GFP-ER promoter targeting by E2 (Figure 5A), or chromatin
decondensation (Figure 5B) and increased transcript accumula-
tion (Figure 5C).
EGF used in combination with E2 induced an increase in array
size similar to that obtained with each factor separately
ERa Function by Image Analyses
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on transcript accumulation at the array (p.0.05, Figure 5C),
which agrees with several previous studies of reporter gene
activation [3,12,23]. However, when PRL-HeLa cells were treated
with AG537 prior to addition of E2 and EGF, transcript levels
were comparable to those obtained with E2 treatment only
(p.0.05, Figure 5C).
Since the MAPK cascade is implicated in ER transcription
regulation [15,16], we treated PRL-HeLa cells with E2 or EGF in
the presence or absence of two different inhibitors of the MAPK
pathway; PD98059 and UO126. Among all cells expressing a low
level of GFP-ER, both inhibitors markedly decreased the
percentage of cells with labeled arrays (66% reduction;
Figure 6A). Conversely, inhibiting the MAPK pathway did not
alter E2-dependent recruitment of ER to the PRL promoter array
(data not shown), clearly showing that E2 and EGF operate
through distinct molecular mechanisms to activate the transcrip-
tional activity of ER.
Serine 118 in ER-mediated PRL array responses
Serine 118 in the ER is a target residue of EGFR initiated signal
transduction cascades including the MAPK pathway [14].
Conversion of this residue to a non-phosphorylable alanine
(GFP-ER-S118A) strongly reduced the number of cells with ER-
positive PRL-arrays after EGF treatment (75% reduction,
Figure 6B). However, this mutation had only a minor effect on
E2-dependent PRL-array targeting (20% reduction) (Figure 6B).
Conversely, replacement by glutamic acid (S118E), which mimics
phosphorylation, targeted the PRL-array similarly to wild-type ER
under both conditions (E2 or EGF). Strikingly, control cells
Figure 3. Large-scale chromatin decondensation of the PRL-array. A. PRL-HeLa cells expressing GFP-ER were treated for different times with
ethanol (vehicle), E2 or EGF. After fixing and counterstaining with DAPI, cells were imaged and the array size was quantified using high throughput
microscopy. B. This panel represents earlier time points to show the slower effect of EGF in inducing maximal decondensation of the array. Data
represent the mean 6SEM of three different experiments. B. PRL-HeLa cells transiently expressing GFP-ER were imaged live at 37uC under constant
perfusion of fresh medium (plus 100 ng/ml EGF after time 0). Image stacks were recorded every four minutes and are presented as projections. The
value indicates the area of the array (mm
2) shown in the image. Addition of EGF caused chromatin decondensation at the array within 30 minutes.
doi:10.1371/journal.pone.0002286.g003
r
Figure 4. ER transcriptional activity at the promoter array. PRL-HeLa cells transiently expressing GFP-ER were treated with E2, EGF, 4-
hydroxytamoxifen (4HT) or ethanolic vehicle for the indicated time. Subsequent to ligand treatment the cells were fixed and subjected to an RNA
FISH protocol using a biotinylated dsRED2 probe followed by fluorescent-tagged streptavidin. A. Representative images of a single cell for each
treatment. The presence of transcripts at the promoter array is identified by accumulated signal above the level for the nucleoplasm. The inset values
(red type) represent the amount of transcript at 2 hours, relative to vehicle controls. B. Representative image of PRL-HeLa cells transfected with GFP-
ER (green) exemplify the heterogeneity of ER expression levels. The cells show the RNA FISH signal associated with the array in the cell population
(red signal) (I). The nuclear GFP-ER mean of fluorescence and RNA FISH array signal were plotted for vehicle- and E2-treated cells. Each symbol
represents the measurements from a singe cell (II). C. To quantify FISH signal over 24 hours the total intensity of signal at the array (minus
background signal) was determined by cumulative summation of 20 planes. Data represent the mean 6SEM of three different experiments graphed
as fold induction over mean time-matched vehicle-treated control cells. D. This panel represents the earlier time points for E2 and EGF treatment.
Fold activation between EGF and E2 at 30 minutes was significantly different, with a p value of 0.03.
doi:10.1371/journal.pone.0002286.g004
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of visible PRL-arrays, indicating that additional ER modification(s)
may be important.
We next analyzed E2- or EGF-induced large-scale chromatin
modification and reporter mRNA transcription simultaneously in
cells expressing GFP-ER phosphomutants. In cells transfected with
GFP-ER-S118A, an increase in the level of mRNA was detected,
which plateaued after 8 hours of E2 treatment, while the PRL-
array was maximally decondensed after 4 hours (Figure 7A). In
contrast, the EGF response was completely abolished in the
presence of GFP-ER-S118A (Figure 7C).
When cells were transfected with a GFP-ER-S118E phospho-
mimic mutant, we observed a 1.5 fold increase in basal PRL-array
size and a significantly higher basal transcript level (2.8 fold) in the
absence of any stimuli (Figure 7B and D, time 0). Moreover,
the responses of this mutant to E2 and EGF were very similar in
terms of chromatin decondensation and transcriptional output
(Figure 7 compare Panel B and D). The highly decondensed
status of the chromatin before treatment was also sustained for
over 24 hours. Somewhat similar to the wild type ER (see
Figure 4C), levels of mRNA accumulation at PRL-arrays
occupied by GFP-ER-S118E exhibit two pulses of FISH signal
accumulation with major peaks at 30 minutes and 12 hours for
estradiol, and 15 minutes and 8 hours for EGF (Figure 7B and
D). The presence of the phosphomutant GFP-ERS118E induces a
maximum peak of transcript levels for EGF at 15 minutes
(p.0.05) (Figure 7B). The accumulation of mRNA at 8 hours
after EGF exposure was similar to E2 at the same time point
(p=0.03) but was significantly lower compared to the second
peaks induced by E2 with GFP-ER wt and GFP-ERS118E
(p.0.05) (Figure 7).
Discussion
It has been well demonstrated that EGF signaling pathways
modulates ER activity [3,14], although the molecular mecha-
nism(s) is not clearly established. The technical complexity of cell-
based assays for promoter binding, chromatin structure, and/or
Figure 5. EGFR signaling and PRL array responses. PRL-HeLa cells transiently transfected with GFP-ER were pretreated or not with Tryphostin
AG537 for 30 minutes before adding ethanol (vehicle), E2, EGF or E2 and EGF together for 2 hours. A. Promoter targeting: after fixing and
counterstaining with DAPI, cells were imaged and the percentage of each cell population that showed visible accumulation at the array in response
to treatment was calculated. Student t-test was performed for EGF treatment compared to each other treatments groups (* p,0.05, { p,0.03). B.
Large-scale chromatin modification: the same images were acquired using high throughput microscopy and the array size was quantified as
described in the Methods. Differences from respective vehicle treatment reaching statistical significance (p,0.05) are labeled by asterisks (*). C.
Transcriptional activity: subsequent to ligand treatment, the cells were fixed and subjected to RNA FISH. The FISH signals at the array were
quantified in .20 cells for each protein and treatment condition and graphed as the average total array-associated fluorescence 6SEM. Student t-
test was performed for each treatment group compared to its control (* p,0.05), or to vehicle ({ p,0.05).
doi:10.1371/journal.pone.0002286.g005
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investigations to each of these individually. The recent develop-
ment of PRL-HeLa provides a useful tool that facilitates the study
of multiple aspects of ER function at the single cell level. This
includes spatiotemporal visualization of ER promoter targeting,
reporter mRNA accumulation and coregulator association, in
either a live or fixed cells [19]. Here, we used the PRL-HeLa
model as a tool to discriminate differences in ligand-dependent
and –independent regulation of ER including receptor binding to
a promoter/enhancer, large-scale chromatin modification, and
induction of transcription. Further, using automated image
acquisition and analyses, we have specifically examined cells that
expressed low levels of transfected protein, avoiding problems
inherent to overexpression and bulk averaging of large populations
of cells. With these approaches we report a time-dependent
signature of large-scale chromatin modification and mRNA
accumulation, which suggests an uncoupling of chromatin
decondensation and maximal transcription.
ER targeting at the site of transcription
The ability of a transcription factor to recognize and bind to
specific elements in a promoter/enhancer is an essential step in
transcription regulation. Initially, we determined that PRL-HeLa
cells expressing only low levels of GFP-ER were heterogeneous in
terms of unliganded ER promoter binding (60%). The respon-
siveness to EGF by ER in PRL-HeLa is less than E2 responses.
Similar to that of E2-induced PRL-array targeting, EGF treatment
resulted in a marked, but relatively sub-maximal increase in the
number of cells with visible arrays (Figure 1). Indeed, compared
to E2, EGF treatments resulted in fewer targeted PRL-arrays in
GFP-ER-expressing cells. As shown in Figure 4C, EGF can
robustly induce a PRL-reporter gene (up to ,80% of mRNA
production compared to E2 levels) in the cells showing a visible
array (78%), but analyses of FISH signals in transfected cells
without a visible array show a transcription level similar to non-
transfected cells (data not shown and [19]). Additionally, when we
examined a narrow range of GFP-ER low-expressing cells for
reporter gene activity by FISH, we still observed variability in gene
expression (Figure 4B). This supports the notion that transcrip-
tional heterogeneity may be a stochastic process [24,25], although
transcription activation tended to peak at 30 minutes after
induction (see below).
Large-Scale Chromatin Modification and Transcription
The fundamental importance of EGF-dependent activation of
ER is further supported by its ability to induce both large-scale
chromatin modification and transcriptional activity over time.
Relative to E2-induced activation, unliganded ER targeting the
PRL-array correlates with a stable, but sub-maximal levels of
chromatin decondensation and mRNA accumulation (Figure 3A
and 4C, and [19]). Our temporal studies indicate that EGF
induces large-scale chromatin modification to a similar degree as
E2, although at about one half the rate (30 minutes vs.
15 minutes). This result is similar to spatiotemporal changes in
GFP-ER nuclear distribution observed in MCF-7 cells (10 minutes
for E2 vs. 30 minutes for EGF) [26]. The physiological significance
of the nuclear reorganization of GFP-ER is unknown as the
concentrated foci are not frequently localized to sites of
transcription [27], and have high exchange dynamics as
determined by photobleaching studies [28]. Although these
EGF-induced nuclear responses are alike, our PRL-array results
here are directly linked to a defined transcription site. Interest-
ingly, despite the delayed induction of large-scale chromatin
modification by EGF-activated GFP-ER as compared to that by
E2, the maximal level of decondensation is similar. It will be
important to determine if a similar set of chromatin remodeling
proteins is involved in each case, and if the recruitment of these
proteins is dependent on coactivator specific post-translational
modifications of ER, or specific modifications to the recruited
coregulators. It will also be important to determine if these large-
scale effects translate to smaller scales of chromatin structure.
After the initial decondensation, large-scale chromatin mod-
ification (as assayed by array size) induced by E2 is sustained for
at least 24 hours. In contrast, continuous EGF treatment
resulted in PRL-array recondensation to basal levels within a
few hours. This differential regulation may be particularly
important for endocrine tissues that require rapid and short
responses to growth factors, in addition to the strong and
sustained E2-dependent transcriptional response. The results of
Figure 6. MAPK signaling and the role ER-S118 in PRL array
responses. A. PRL-HeLa cells transiently expressing GFP-ER were
treated with 50 mM PD98589 or 10 mM UO126 for 30 minutes before
adding 10 nM E2 or 100 ng/ml EGF for 2 h. The percentage of each cell
population that showed visible accumulation at the array in response to
treatment was calculated and reported in the graphs (n.200). Both
inhibitors dramatically reduced the number of GFP-ER-targeted arrays
in transfected cells (EGF treated only) p,0.05. B. Percentage of cells
with a visible array in PRL-HeLa cells transiently transfected with GFP-ER
or with the two mutants, GFP-ERS118A and GFP-ERS118E, and treated
with ethanol, E2 or EGF for 2 hours. Student t-test was performed for
each bar compared to GFP-ER (* p,0.05), or to vehicle ({ p,0.05).
doi:10.1371/journal.pone.0002286.g006
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tion following continuous EGF treatment correlate with our
observations of the temporal response of PRL-array decondensa-
tion to EGF. This suggests that the effect of EGF is modulated by
down-regulation of EGFR at the plasma membrane [29,30].
However, EGF withdrawal results in a faster rate of condensa-
tion of the PRL-array (Figure S2), suggesting an active yet time-
limited role of the EGF-EGFR interaction in maintaining the
promoter in an ‘‘open state’’ for transcription.
Temporal cycling
Our previous report focused upon the early events in PRL-array
transcription activity (#2 hrs) and [19]. To obtain a more
comprehensive temporal picture of ER function in response to
ligand-dependent and –independent activation, we determined the
relationship between large-scale chromatin alterations and mRNA
accumulation over 24 hours. Our results suggest a time-depen-
dent, stimulus-specific regulation of mRNA synthesis mediated by
ER. Time course experiments show a cyclical pattern of reporter
gene mRNA accumulation at the PRL-array in the continual
presence of E2, which was markedly different to the non-cyclic
pattern of transcription induced by sustained presence of EGF. An
interesting question that we are addressing is: does ER
phosphorylation cycle in phase with transcript accumulation?
However, our data are in accord with data showing that P-Ser118
increased between 15 and 60 minutes following E2 treatment, as
opposed to 15 and 30 minutes for EGF [31].
Cyclical ER function has been previously reported. Several
groups have shown via chromatin immunoprecipitation (ChIP)
analysis that levels of ER, coregulators, and RNA polymerase II
crosslinked at endogenous promoters (c-Myc, pS2), can cycle at
20–40 minute intervals, dependent upon E2 treatment subsequent
to transcription synchronization by promoter clearance [32–34].
To complement the ChIP studies, nuclear run-on assays
performed on target genes [34] also revealed a significant cyclic
pulse of E2-induced transcription at 45 minutes and 2 hours.
Thus, both single cell studies and pooled biochemical studies
demonstrate the cyclical nature of ER induction of transcription,
although differing in frequency.
An intriguing in vivo corollary is the finding that a single
injection of estradiol in ovariectomized rats at noon on day zero
induced a peak of prolactin mRNA content at 8:00 PM for three
days after treatment [35]. This response to estrogen is vital for a
daily surge of prolactin release by the pituitary, which is important
for maintenance of the corpora lutea in pregnancy [36].
Accordingly, it will be important to determine if other E2
responsive promoters such as myc and pS2 demonstrate similar
cyclic activity.
The results obtained from biochemical approaches (ChIP) are
obtained from millions of cells and, thus, are averaged responses
Figure 7. Temporal single-cell analyses of ER-S118A and ER-S118E transcriptional response at the PRL-array. PRL-HeLa cells transiently
expressing the two phosphomutants, GFP-ERS118A (panel A and C) or GFP-ERS118E (panel B and D), were treated with either ethanol, E2 (panel A
and B) or EGF (panel C and D) for different times. Subsequent to ligand treatment, the cells were fixed and subjected to RNA FISH using a biotinylated
dsRED2 probe followed by fluorescent-tagged streptavidin. The FISH signal at the array was determined as described and the value graphed as fold
induction over vehicle control cells (solid line). For each cell the area of the array was also determined and plotted as fold induction over vehicle
control (dotted line). Data represent the mean 6SEM of three different experiments graphed as fold induction over time-matched vehicle-treated
control cells.
doi:10.1371/journal.pone.0002286.g007
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nuclear receptors and other transcription factors rapidly exchange
with a promoter array at a much faster rate (seconds [19,25,37–
40]). A reconciling model posits that transcription initiates by
virtue of infrequent yet stable and productive association of factors
at target genes (ChIP). These events are the result of many rapid
and stochastic unproductive associations of transcription factors
(FRAP). This model received substantial supportive evidence by a
study of a naturally repeated gene in yeast [25]. Recent
quantitative measurement in prokaryotic and eukaryotic cells also
suggests that gene expression might involve intermittent pulses
[41] that are stochastically regulated. Therefore, in order to
achieve regulated transcription, activation-induced events must be
synchronized in a spatiotemporal context. The result of synchrony
would yield a higher mean transcript amount at the promoter
level. Conversely, the loss of synchrony would result in periodic
reduction (at 2 hrs and 12 hrs) of the mean transcription level of
the population (cycling). In the context of the ‘‘visual-ChIP’’
system presented here, we demonstrate that synchronization is a
natural process that is achieved by the addition of E2 or EGF.
Furthermore, the mechanism of transcription synchronization in
this model system is independent of large-scale chromatin
modification.
A disconnection between chromatin decondensation
and transcription
The discoveries that chromatin structure influences transcrip-
tion have expanded upon the static model based on response
elements as a straightforward platform for intermediate complexes
and basal transcriptional machinery [42]. The understanding of
how chromatin remodeling can mechanistically affect gene
regulation requires additional insight into the kinetics of the
process. This includes how quickly such changes can be generated,
how long they are maintained, and if they correlate precisely with
transcription. Transcriptional activity, visualized here as accumu-
lation of transcripts at the PRL-array, correlates with the presence
of active transcriptional machinery on the promoter that could
sterically impede DNA rewrapping before the transcriptional
activity ends. The condensed status of the array chromatin
visualized in 4HT treated cells (see Figure 3A) link both the loss of
RNA polymerase II recruitment and transcription with a repressed
locus while E2 and EGF induce chromatin decondensation and
increase transcription at the locus. By themselves, these results
suggest a direct correlation between transcription and chromatin
status. However, temporal analysis of chromatin condensation and
transcription indicates a more complex picture. At basal
chromatin condensation (unliganded ER, EGF-treated wt-ER
after 12 hrs, or ER-S118A) reporter gene mRNA accumulation is
indistinguishable. Despite the constant presence of a presumably
open and transcriptionally permissive state of the chromatin (wt-
ER upon E2 treatment, or ER-S118E transfected cells treated with
E2 and EGF), a maximal sustained level of mRNA accumulation is
not observed indicating that decondensed chromatin is necessary,
but not sufficient for sustained high rates of transcription. In this
scenario, the presence of an open array would allow continuous
sampling of the stimuli exposure. The unexpected result of
Ser118E transcriptional cycling in the presence of EGF leads us to
attribute the higher response of this mutant to a lack of negative
feedback on its activity rather than to a stronger activation of the
mutant itself.
Serine 118 of the ER plays a particularly important role both for
E2 and EGF responses [16,30]. For ligand-independent ER
activation, control of phosphorylation at this site may provide an
important negative feedback function on transcriptional activity
and consequently on the chromatin structure at the promoter level
in ER ligand-independent activation. Note in Figure 6B, there is
a sharp reduction in targeted arrays in cells expressing GFP-ER-
S118A, which have been treated with EGF. This is consistent with
results from cells expressing GFP-ER that have been treated with
EGF and tyrphostin (Figure 5A), which is discussed further
below. Indeed, the phosphorylation of ER Serine 118 appears
necessary to permit EGF induced large-scale chromatin modifi-
cation in PRL-HeLa (Figure 7) and it also plays a partial role in
E2-dependent activation of transcription. Results using the mutant
ER-S118E receptor provide strong evidence for the critical role of
phosphorylation of this residue in contributing to PRL-array
modification. This mutation mimics a phosphorylated state of
serine and induces a sustained decondensed PRL-array. These
results suggest that ER phosphorylation alters receptor function
(promoter targeting, chromatin remodeling and transcriptional
output) effecting changes that could lead to a more sensitive
response to EGF stimuli, as reported for tamoxifen-resistant breast
tumors [43,44]. Our results also clearly show that this residue is
not only important for ER binding to the promoter, it also has a
crucial role in ensuring a transcriptional response to EGF, and in
regulating the temporal cycling of transcription accumulation in
response to E2.
The role of EGF signaling pathway on ER function
It is widely accepted that EGF indirectly activates ER
transcription in the absence of its cognate ligand through binding
to the cell membrane EGF receptor (EGFR), dimerization of the
receptor and signal transduction through kinase pathways
(including Ras/Raf/MAPK pathway [45]). The direct inhibition
of EGFR by Tyrphostin AG537, and its downstream signal
transducer, MKK1 kinase, by UO126 or PD98589 reduces EGF
activation of ER, as determined by the proportion of responsive
cells in our assays. Interestingly, after EGF treatment, the
reduction of PRL-array targeted cells in the presence of these
inhibitors was less than in control cells and is consistent with
reduced array occupancy by ER-S118A (Figure 6B) or the AF-1
deletion mutant (Figure 2). This antagonist-like effect of EGF
(20% versus 60%, Table 1 and Figure 6) indicates the possibility
that array occupancy is modulated when ER phosphorylation is
indirectly, or directly, inhibited (Figure 5 and Figure 6
respectively). To dynamically control output signals, the EGFR
signaling cascade may have evolved positive- and negative-
feedback circuits [11]. The latter mechanism may participate in
signal attenuation where cells can tune their response to various
mixed stimuli. It is possible that when EGF and kinase inhibitor (or
phosphomutant) are both present, the negative-feedback mode
would dominate, perhaps by altering the phosphocode (and
interactions) of ER and coregulators [46]. In this case, the end
result would be a decrease in promoter targeting. In support of this
argument, EGF stimulation of SRC-3 has been shown to alter its
nuclear accumulation and occupancy of the PRL-array through
changes in specific SRC-3 phosphorylation sites [47].
Perspectives
The importance of transcription in cell growth and differenti-
ation is underlined by the redundancy of feedback mechanisms
that regulate those processes (different combination of events to
achieve the same result in controlling gene expression). The results
of this study further an emerging systems biology level view, which
suggests an increased coherent understanding of gene transcription
requires not only knowledge of which molecular players are
involved but how they interact within the context of cell temporal/
structure/organization [44,48]. As the multiplex systems level
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speed, the resultant avalanche of terabytes of image data per
experiment will provide unprecedented data-mining opportunities,
and challenges. Current studies focusing upon a spatiotemporal
fingerprint of receptor and coregulator levels at the PRL locus, or
other regulated gene arrays, should yield additional key insights
into the orchestration of the molecular and cellular events involved
in gene expression.
Materials and Methods
Cell culture
For all experiments using PRL-HeLa, cells were grown a
minimum of two days in hormone-free medium containing
stripped and dialyzed fetal bovine serum. Transient transfection
of ER and ER mutant expression vectors was performed using the
Bio-Rad Transfectin reagent following the manufacturer’s proto-
col. After transfection the medium was replaced with ligand
containing media and treated for the desired length of time.
Immunolabeling
Antibody labeling was performed as described previously
[19,49] using 4% formaldehyde fixation (30 min) and indirect
labeling with Alexa 488, 546 or 633(Molecular Probes) conjugated
secondary antibodies. DAPI (1 mg/ml) was used to label DNA
prior to mounting in Slow Fade (Molecular Probes). Affinity-
purified rabbit antibodies to SRC-1 and SRC-3 were a kind gift
from Dr. Jeimin Wong; CDK9, CyclinT1, BRG-1 and RNA Pol II
large subunit were obtained from Abcam or Upstate Biotechnol-
ogy and all used at 1 mg/ml for 1 hr at room temperature or
overnight at 4uC.
RNA FISH
The methods used here, including procedures for non-isotopic
probe preparation and fluorescent in situ hybridization, have been
published in detail [50] Briefly, coverslips with adherent cells were
rinsed twice in PBS, dipped in cytoskeleton (CSK) buffer (100 mM
NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM PIPES, pH 6.8)
[51], extracted on ice for 5 minutes in CSK buffer containing
0.5% Triton X-100 and 2 mM vanadyl-ribonucleoside complex
(VRC; Gibco-BRL), rinsed in CSK/VRC, fixed in 4% parafor-
maldehyde/PBS for 10 minutes, rinsed again in PBS and stored in
0.4% paraformaldehyde at 4uC until use. Probes substituted with
biotin-labeled deoxynucleotides were made by modifications to
standard nick translation procedures [50] Hybridization to RNA
was carried out at 37 C in standard buffers containing 5 mg/ml
probe and 50% formamide overnight. After incubation, samples
were rinsed in a series of SSC buffers, assayed for biotin using
streptavidin, Alexa Fluor 546 conjugate (Molecular Probes,
Eugene, OR) and rinsed in a series of PBS washes. Cells were
counter-stained with 1 mg/ml DAPI (Sigma, St. Louis, MO).
Coverslips were then mounted on slides in Slow Fade (Molecular
Probes). To quantify FISH signals, a 20 plane 1286128 (pixels), 0.
2 mm Z-stack was collected (constant exposure). Images were
acquired on a Deconvolution Microscope, deconvolved and sum
projected. The RNA FISH signals were quantified by using
MetaMorph software (Universal Imaging, Downingtown, Pa.)
after subtraction of the background nuclear fluorescence as
previously described [40].Then, the integrated total RNA FISH
intensity was calculated for each condition and normalized to the
level of integrated total RNA FISH intensity in untreated cells to
obtain the relative RNA FISH intensity. Linescans were created
using SigmaPlot (Systat Software, Inc., San Jose, CA).
Fixed Cell and Time-Lapse Imaging
The XFP-fusions and immunofluorescently labeled cells were
imaged using a DeltaVision Restoration Microscopy system
(Applied Precision, Issaqua, WA) and applying a constrained
iterative deconvolution process. Whole nuclear volumes were
collected at 0.2 mm Z steps and images from select focal planes or
3D projections were imported into Adobe PhotoShop. The
Histogram adjustments were made relevant to negative controls,
which routinely included non-transfected cells and/or omission of
primary antibodies. Live imaging was performed by collecting
short Z-stacks (,5–10 focal planes at 300 nm increments); neutral
density for the green channel was set at 50% and the images were
binned 262. Typical exposures were for ,1 sec, and time points
from 3–10 minutes per stack. Projected images from each time
point were used to create a QuickTime movie. Cells for live
imaging were grown in 35 mm Delta T dishes (Bioptechs, Butler,
PA) and secured to a stage adapter for temperature control.
HEPES-buffered media was gassed overnight in a 5% CO2
incubator, and circulated through the Delta T dish using a
Bioptechs peristaltic pump and inflow/outflow tubing. The
temperature was controlled to 37uC( 6,0.1 degree); a Bioptechs
objective heating collar was also used (also at 37uC). The Delta T
dish was covered with a black plastic lid, with room for input/
output tubing. For time-lapse imaging, a 636objective (NA=1.4)
was used.
Quantitative Image Analyses by HTM
The PRL-HeLa cells transiently expressing GFP-ER were
treated with E2, 4HT, or EGF for the time indicated, fixed, and
DAPI stained. The cells were imaged using the Cell Lab IC 100
I m a g eC y t o m e t e r( B e c k m a nC o u l t e r )w i t haN i k o n4 0 6 Plan S
fluor 0.90 NA objective. Two channels were imaged: channel 0
(DAPI) was used to find the focus and nuclei and channel 1 was
used to image GFP-ER. A proprietary algorithm (GPCR)
developed at Beckman Coulter was used to identify and quantify
the GFP-ER targeted PRL-array. The parameters for the GPCR
algorithm were: object scale=30 and minimum peak
height=10. Foci identified by the GPCR algorithm are masked.
The area of the mask in pixels is the measure of PRL-array size.
Channel 1 was offset 2 mmf r o mt h eD A P If o c u sf o rc e l l si na l l
treatment conditions. This offset provided the greatest number of
in focus arrays identified by the GPCR algorithm. After image
acquisition and application of the GPCR algorithm the total cell
populations for each treatment were progressively filtered (gated)
u s i n gt h es a m ec r i t e r i a .N u c l e ic l u s t e r s ,m i t o t i cc e l l s ,a n d
apoptotic cells were filtered from the total cell population using
an intersection of DNA content and DNA clusters gates. In
addition, low GFP-ER expression and low aggregate number
gates were generated and applied to produce the final cell
population to be analyzed. The maximum fluorescence detected
of endogenous ER in MCF-7 cell line is determined as total
fluorescence in the cell. The maximum threshold for exogenous
ER expression detected by immunofluorescence in PRL-HeLa
cells is conservatively set to 2 times the endogenous level. The
corresponding range for green fluorescence of exogenous GFP-
ER is determined and used for subsequent imaging. From the
final population of cells, the array size was determined using the
GPCR mask. The images and masks were visually inspected for
accuracy. The data was imported into SigmaPlot via an Excel
Spreadsheet and fit to a single exponential decay to obtain the
dissociation rate constant. Unpaired Students t-tests assuming
equal variance were performed to determine statistical signifi-
cance (two-tailed, p,0.05).
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Figure S1 Assessment of ER ability to recruit coactivators to the
promoter array. PRL-HeLa cells transiently expressing GFP-ER,
were treated with 10 nM E2, 100 ng/ml EGF or ethanolic vehicle
for 2 hours. Subsequent to ligand treatment the cells were fixed
and endogenous coactivators (SRC-1, -3, BRG1, CDK9 and
CyclinT1) detected by immunofluorescence (red). The presence of
each coactivator at the promoter array is identified by accumu-
lated signal above the level for the nucleoplasm, and representative
images are illustrated here as a merge. The size bar is in microns.
Found at: doi:10.1371/journal.pone.0002286.s001 (2.60 MB TIF)
Figure S2 Stimuli withdrawal regulates large-scale chromatin
modification: PRL-HeLa cells were transiently transfect with GFP-
ER and then treated with 10 nM E2 or 100 ng/ml EGF for
30 min (time=0). After this time the cells were washed 5 times
with PBS and the medium replaced with medium without Phenol
Red and 5% SDFBS. The cells were then fixed at the indicated
times, stained with DAPI and imaged with the HTM in order to
quantify the array size. Results are expressed as array size
normalized to control cells obtained from three independent
experiments. The graph representing the cells without replace-
ment of the stimuli (full line) is indicated for comparison. The
decay rates were as follows: E2 withdrawal=0.29/h; EGF
withdrawal=0.16/h; EGF=0.026/h.
Found at: doi:10.1371/journal.pone.0002286.s002 (0.20 MB TIF)
Figure S3 Assessment of ER ability to recruit RNA Polymerase
II. PRL-HeLa cells transiently expressing GFP-ER, were treated
with 10 nM E2, 100 ng/ml EGF, 10 nM 4HT or ethanolic
vehicle for 2 hours. Subsequent to ligand treatment, the cells were
fixed and endogenous RNA Polymerase IIo detected by
immunofluorescence (red). The presence of GFP-ER and the
transcription factor RNA Pol II on the promoter array is visualized
as signal accumulation above the nucleoplasm level. In 4-hydroxy-
tamoxifen-treated cells, RNA Polymerase IIo signal is not present
at the promoter array, as identified by GFP-ER accumulation.
The size bar is in microns.
Found at: doi:10.1371/journal.pone.0002286.s003 (4.17 MB TIF)
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